Literature DB >> 9220309

Human leukocyte antigen class II associations in patients with idiopathic dilated cardiomyopathy. Myocarditis Treatment Trial Investigators.

M D Lozano1, R J Rubocki, J E Wilson, B M McManus, J L Wisecarver.   

Abstract

BACKGROUND: Idiopathic dilated cardiomyopathy (IDC) is a disease of unknown etiology for which immune abnormalities, possibly related to viral infections, are suspected but unproven. Previous serologic studies have reported associations between human leukocyte antigen DR4 and IDC. A molecular study of human leukocyte antigen associations was undertaken in patients with IDC to further explore the possibility of susceptibility markers of genetically determined disease. METHODS AND
RESULTS: In this study, 36 patients from the Myocarditis Treatment Trial (32 IDC and 4 myocarditis patients) were examined using restriction fragment length polymorphism analysis and polymerase chain reaction amplification with sequence-specific primers to perform class II typing. All 4 myocarditis patients were DQ5 positive and 3 possessed the allele DQB1*0501. In the IDC group, the frequency of human leukocyte antigen DR4 was similar to that reported in the normal population. In addition, there was no excess prevalence of any molecularly defined DR4 alleles (0401-0419). There was an increase in the frequency of DR12 in IDC patients. The frequencies of the alleles DQB1 *0503 and DQB1*0301 and/or *0304 were also increased in IDC patients versus the normal population.
CONCLUSION: The molecular studies point to a relationship between the DQ locus and IDC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220309     DOI: 10.1016/s1071-9164(97)90041-5

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  11 in total

1.  Systems analysis of gene ontology and biological pathways involved in post-myocardial infarction responses.

Authors:  Nguyen T Nguyen; Merry L Lindsey; Yu-Fang Jin
Journal:  BMC Genomics       Date:  2015-06-11       Impact factor: 3.969

Review 2.  Cardiac Autoimmunity: Myocarditis.

Authors:  William Bracamonte-Baran; Daniela Čiháková
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

3.  A meta-analysis of HLA-DR polymorphism and genetic susceptibility to idiopathic dilated cardiomyopathy.

Authors:  Bo Jin; Xin-Ping Luo; Huan-Chun Ni; Wei Shen; Hai-Ming Shi; Yong Li
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

4.  Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice.

Authors:  Veena Taneja; Marshall Behrens; Leslie T Cooper; Satsuki Yamada; Hirohito Kita; Margret M Redfield; Andre Terzic; Chella David
Journal:  J Mol Cell Cardiol       Date:  2007-03-27       Impact factor: 5.000

5.  Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD mice.

Authors:  John F Elliott; Junliang Liu; Zuan-Ning Yuan; Norma Bautista-Lopez; Sarah L Wallbank; Kunimasa Suzuki; David Rayner; Patrick Nation; Murray A Robertson; Gang Liu; Katherine M Kavanagh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-21       Impact factor: 11.205

6.  Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo transgenic mice.

Authors:  Veena Taneja; Chella S David
Journal:  J Autoimmun       Date:  2009-10-07       Impact factor: 7.094

Review 7.  Genetic complexity of autoimmune myocarditis.

Authors:  Haiyan S Li; Davinna L Ligons; Noel R Rose
Journal:  Autoimmun Rev       Date:  2007-12-03       Impact factor: 9.754

Review 8.  Myocarditis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Prog Cardiovasc Dis       Date:  2010 Jan-Feb       Impact factor: 8.194

Review 9.  Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events.

Authors:  Esmée P Hoefsmit; Elisa A Rozeman; John B A G Haanen; Christian U Blank
Journal:  ESMO Open       Date:  2019-07-21

Review 10.  HLA-DR3 antigen in the resistance to idiopathic dilated cardiomyopathy.

Authors:  B Jin; B W Wu; Z C Wen; H M Shi; J Zhu
Journal:  Braz J Med Biol Res       Date:  2016-03-18       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.